Rational design of indoleamine 2,3-dioxygenase inhibitors Journal Article


Authors: Róhrig, U. F.; Awad, L.; Grosdidier, A.; Larrieu, P.; Stroobant, V.; Colau, D.; Cerundolo, V.; Simpson, A. J. G.; Vogel, P.; van den Eynde, B. J.; Zoete, V.; Michielin, O.
Article Title: Rational design of indoleamine 2,3-dioxygenase inhibitors
Abstract: Indoleamine 2,3-dioxygenase (IDO) is an important therapeutic target for the treatment of diseases such as cancer that involve pathological immune escape. We have used the evolutionary docking algorithm EADock to design new inhibitors of this enzyme. First, we investigated the modes of binding of all known IDO inhibitors. On the basis of the observed docked conformations, we developed a pharmacophore model, which was then used to devise new compounds to be tested for IDO inhibition.We also used a fragment-based approach to design and to optimize small organic molecule inhibitors. Both approaches yielded several new low-molecular weight inhibitor scaffolds, the most active being of nanomolar potency in an enzymatic assay. Cellular assays confirmed the potential biological relevance of four different scaffolds. © 2010 American Chemical Society.
Keywords: unclassified drug; human cell; nonhuman; cell proliferation; animal cell; mouse; animals; mice; cells, cultured; unindexed drug; enzyme inhibition; primaquine; drug potency; small molecule libraries; cell assay; drug design; structure-activity relationship; enzyme inhibitors; models, molecular; pharmacophore; indoleamine-pyrrole 2,3,-dioxygenase; molecular weight; enzyme assay; drug binding; triazole derivative; tryptophan; kynurenine; quinoline derivative; 2 mercaptobenzothiazole; 2 phenoxyaniline; 4 (benzylamino) 1 naphthol; 4 (cyclohexylamino) 1 naphthol; 4 (ethylamino) 1 naphthol; 4 (isobutylamino) 1 naphthol; 4 (isopropylamino) 1 naphthol; 4 (pent 3 ylamino) 1 naphthol; 4 (propylamino) 1 naphthol; 4 amino 1 naphthol; 4 hydroxycarbazole; 5 (ethylamino)quinolin 8 ol; 5 (isopropylamino)quinolin 8 ol; 5 amino 8 hydroxyquinoline; 9 fluorenone; 9 hydroxyfluorenone; benzophenone; benzothiazole; benzothiazole derivative; dichlorophen; indoleamine 2,3 dioxygenase inhibitor; n (4 hydroxy 1 naphthyl)ethane 1,2 diaminium chloride; n phenyl 4 phenylenediamine; naphthalene derivative; phenylthiazole; phenylthiazole derivative; drug conformation
Journal Title: Journal of Medicinal Chemistry
Volume: 53
Issue: 3
ISSN: 0022-2623
Publisher: American Chemical Society  
Date Published: 2010-02-11
Start Page: 1172
End Page: 1189
Language: English
DOI: 10.1021/jm9014718
PUBMED: 20055453
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 20 April 2011" - "CODEN: JMCMA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew John Simpson
    31 Simpson